Scientists track immune clues in breast and ovarian tumors

NCT ID NCT04562623

Recruiting now Knowledge-focused Sponsor: Centre Leon Berard Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is looking at how the immune system responds to breast and ovarian cancers. Researchers will analyze tumor and blood samples from 160 women before surgery to understand immune cell activity and find markers that might predict survival. The goal is to learn more about how the body fights these cancers, not to test a new treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could help identify which patients might respond better to certain treatments, leading to more personalized care.
What could go wrong: This is an observational study, not a treatment trial. It will not directly improve outcomes, and findings may not lead to immediate changes in care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast carcinoma breast neoplasm ovarian cancer ovarian carcinoma ovarian serous adenocarcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BREAST CARCINOMA OVARIAN CARCINOMA

Contacts and locations

Locations

Centre Léon Bérard
RECRUITING

Lyon, France, 69008, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.